相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Human microtubule-associated protein tau mediates targeted killing of CD30+ lymphoma cells in vitro and inhibits tumour growth in vivo
Dmitrij Hristodorov et al.
BRITISH JOURNAL OF HAEMATOLOGY (2014)
Granzyme M as a novel effector molecule for human cytolytic fusion proteins: CD64-specific cytotoxicity of Gm-H22(scFv) against leukemic cells
Sonja Schiffer et al.
CANCER LETTERS (2013)
被撤回的出版物: World Medical Association Declaration of Helsinki Ethical Principles for Medical Research Involving Human Subjects (Retracted article. See vol. 135, pg. 2149, 2021)
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)
In vivo efficacy of the recombinant anti-CD64 immunotoxin H22(scFv)-ETA′ in a human acute myeloid leukemia xenograft tumor model
Mehmet Kemal Tur et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Generation of recombinant antibody fragments that target canine dendritic cells by phage display technology
J. Fitting et al.
VETERINARY AND COMPARATIVE ONCOLOGY (2011)
Induction and increase of HLA-DR antigen expression by immune interferon on ML-3 cell line enhances the anti-HLA-DR immunotoxin activity
M. CHIRON et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2010)
Site-Specific, Covalent Labeling of Recombinant Antibody Fragments via Fusion to an Engineered Version of 6-O-Alkylguanine DNA Alkyltransferase
Florian Kampmeier et al.
BIOCONJUGATE CHEMISTRY (2009)
Allogeneic hematopoietic cell transplantation after conditioning with 131I-anti-CD45 antibody plus fludarabine and low-dose total body irradiation for elderly patients with advanced acute myeloid leukemia or high-risk myelodysplastic syndrome
John M. Pagel et al.
BLOOD (2009)
Immunokinases, a Novel Class of Immunotherapeutics for Targeted Cancer Therapy
Mehmet Kemal Tur et al.
CURRENT PHARMACEUTICAL DESIGN (2009)
Improved Immunotoxins with Novel Functional Elements
C. Hetzel et al.
CURRENT PHARMACEUTICAL DESIGN (2009)
A novel AML-selective TRAIL fusion protein that is superior to Gemtuzumab Ozogamicin in terms of in vitro selectivity, activity and stability
B. ten Cate et al.
LEUKEMIA (2009)
Kinetics of anti-carcinoembryonic antigen antibody internalization: effects of affinity, bivalency, and stability
Michael M. Schmidt et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2008)
Small cleavable adapters enhance the specific cytotoxicity of a humanized immunotoxin directed against CD64-positive cells
Christian Hetzel et al.
JOURNAL OF IMMUNOTHERAPY (2008)
Granzyme B-H22(scFv), a human immunotoxin targeting CD64 in acute myeloid leukemia of monocytic subtypes
Bettina Stahnke et al.
MOLECULAR CANCER THERAPEUTICS (2008)
Antibody therapy for acute myeloid leukemia
Deborah Mulford
SEMINARS IN HEMATOLOGY (2008)
Increasing anticarcinoma activity of an anti-erbB2 recombinant immunotoxin by the addition of an anti-EpCAM sFv
Brad J. Stish et al.
CLINICAL CANCER RESEARCH (2007)
Monoclonal antibodies for the treatment of acute myeloid leukemia
Syed A. Abutalib et al.
CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2006)
The SWISS-MODEL workspace: a web-based environment for protein structure homology modelling
K Arnold et al.
BIOINFORMATICS (2006)
SWISS-MODEL: an automated protein homology-modeling server
T Schwede et al.
NUCLEIC ACIDS RESEARCH (2003)
Secretion of functional anti-CD30-angiogenin immunotoxins into the supernatant of transfected 293T-cells
M Stöcker et al.
PROTEIN EXPRESSION AND PURIFICATION (2003)
The difficult problem of acute myeloid leukemia in the older adult
RM Stone
CA-A CANCER JOURNAL FOR CLINICIANS (2002)
Rhenium 188-labeled anti-CD66 (a, b, c, e) monoclonal antibody to intensify the conditioning regimen prior to stem cell transplantation for patients with high-risk acute myeloid leukemia or myelodysplastic syndrome:: results of a phase I-II study
D Bunjes et al.
BLOOD (2001)
Cell surface receptor-targeted therapy of acute myeloid leukemia: A review
AE Frankel et al.
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS (2000)
Compatible-solute-supported periplasmic expression of functional recombinant proteins under stress conditions
S Barth et al.
APPLIED AND ENVIRONMENTAL MICROBIOLOGY (2000)